SCHEMBL28774232

SCHEMBL28774232

CC=CNC(=O)Nc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 5/20 0.59
▸ EPHX1 P07099 2/20 0.59
▸ TP53 P04637 1/20 0.59
▸ TSHR P16473 1/20 0.59
▸ EPHX2 P34913 1/20 0.59
▸ CDK9 P50750 1/20 0.59
▸ CLK4 Q9HAZ1 1/20 0.59
▸ NPC1 O15118 5/20 0.57
▸ RAB9A P51151 5/20 0.57
▸ ALDH1A1 P00352 2/20 0.57
▸ TAAR1 Q96RJ0 3/20 0.53
▸ KMT2A Q03164 3/20 0.53
▸ MAPT P10636 3/20 0.53
▸ KDM4E B2RXH2 3/20 0.53
▸ MEN1 O00255 2/20 0.53
▸ LMNA P02545 1/20 0.53
▸ CASP3 P42574 1/20 0.52
▸ SENP7 Q9BQF6 1/20 0.52
▸ ACP1 P24666 2/20 0.52
▸ MAOA P21397 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11271173 0.91 SMN1; SMN2 (0.53) SMN1; SMN2EPHX1TP53TSHREPHX2
SCHEMBL11271177 0.91 SMN1; SMN2 (0.53) SMN1; SMN2EPHX1TP53TSHREPHX2
SCHEMBL7908202 0.84 SMN1; SMN2 (0.64) SMN1; SMN2EPHX1TP53TSHREPHX2
SCHEMBL19398197 0.79 ALDH1A1 (0.79) SMN1; SMN2EPHX1TP53TSHREPHX2
SCHEMBL27599974 0.78 SMN1; SMN2 (0.67) SMN1; SMN2EPHX1TP53TSHREPHX2
SCHEMBL10722683 0.78 RAB9A (0.50) SMN1; SMN2EPHX1TP53TSHREPHX2
SCHEMBL10722691 0.78 RAB9A (0.50) SMN1; SMN2EPHX1TP53TSHREPHX2
SCHEMBL11264598 0.78 MTOR (0.46) SMN1; SMN2EPHX1TP53TSHREPHX2
SCHEMBL11264594 0.78 MTOR (0.46) SMN1; SMN2EPHX1TP53TSHREPHX2
Diphenylurea SCHEMBL133103 0.76 SMN1; SMN2 (1.00) SMN1; SMN2EPHX1TP53TSHREPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101238131-A Bridged piperazine and piperidine derivatives as CCR1 antagonists NOVARTIS AG (CH) 2008-08-06 — — CN disclosed
Send feedback